HU9502068D0 - N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders - Google Patents

N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders

Info

Publication number
HU9502068D0
HU9502068D0 HU9502068A HU9502068A HU9502068D0 HU 9502068 D0 HU9502068 D0 HU 9502068D0 HU 9502068 A HU9502068 A HU 9502068A HU 9502068 A HU9502068 A HU 9502068A HU 9502068 D0 HU9502068 D0 HU 9502068D0
Authority
HU
Hungary
Prior art keywords
cholecystokinin
gastrin
drugs
prevention
treatment
Prior art date
Application number
HU9502068A
Other languages
Hungarian (hu)
Other versions
HUT74094A (en
Inventor
Marc Capet
Marie-Christine Dubroeucq
Franco Manfre
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of HU9502068D0 publication Critical patent/HU9502068D0/en
Publication of HUT74094A publication Critical patent/HUT74094A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PCT No. PCT/FR94/00009 Sec. 371 Date Jun. 28, 1995 Sec. 102(e) Date Jun. 28, 1995 PCT Filed Jan. 3, 1994 PCT Pub. No. WO94/15915 PCT Pub. Date Jul. 21, 1994The present invention relates to derivatives of formula: <IMAGE> (I) to their salts, to their preparation and to the medicaments containing them.
HU9502068A 1993-01-07 1994-01-03 Pyrrolidine derivatives, pharmaceutical compositions containing them and process for producing them HUT74094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300078A FR2700166B1 (en) 1993-01-07 1993-01-07 Pyrrolidine derivatives, their preparation and the drugs containing them.

Publications (2)

Publication Number Publication Date
HU9502068D0 true HU9502068D0 (en) 1995-09-28
HUT74094A HUT74094A (en) 1996-11-28

Family

ID=9442867

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9502068A HUT74094A (en) 1993-01-07 1994-01-03 Pyrrolidine derivatives, pharmaceutical compositions containing them and process for producing them

Country Status (18)

Country Link
US (1) US5707991A (en)
EP (1) EP0678089B1 (en)
JP (1) JPH08505849A (en)
KR (1) KR960700229A (en)
AT (1) ATE143947T1 (en)
AU (1) AU5819394A (en)
CA (1) CA2152185A1 (en)
DE (1) DE69400704T2 (en)
DK (1) DK0678089T3 (en)
ES (1) ES2094638T3 (en)
FR (1) FR2700166B1 (en)
GR (1) GR3021314T3 (en)
HU (1) HUT74094A (en)
IL (1) IL108288A0 (en)
NO (1) NO952688L (en)
NZ (1) NZ259399A (en)
WO (1) WO1994015915A1 (en)
ZA (1) ZA9429B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2721608B1 (en) * 1994-06-22 1996-07-19 Rhone Poulenc Rorer Sa Thiazolidine derivatives, their preparation and the drugs containing them.
FR2734724B1 (en) * 1995-06-01 1997-07-04 Rhone Poulenc Rorer Sa APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF ALCOHOLISM
FR2744362B1 (en) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIES OR EXCESSIVE USE
AR021803A1 (en) * 1998-09-23 2002-08-07 Merck & Co Inc PERFECTED STEREOSELECTIVE PROCESS FOR ENALAPRIL.
ITRM20020014A1 (en) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti DERIVATIVES OF A-PHENYLTHIOCARBOXYL AND A-PHYLYOXYCARBOXYL ACIDS USEFUL FOR THE TREATMENT OF DISEASES THAT RESPOND TO THE ACTIVATION OF
ES2350977T3 (en) 2002-11-05 2011-01-28 Glaxo Group Limited ANTIBACTERIAL AGENTS.
EP2386539B1 (en) * 2005-12-23 2016-07-20 Zealand Pharma A/S 4-Aminoproline derivatives useful as lysine mimetics
WO2008079266A2 (en) * 2006-12-21 2008-07-03 Wyeth Synthesis of pyrrolidine compounds
ES2870106T3 (en) 2017-05-05 2021-10-26 Zealand Pharma As Modulators of gap junctional communication and their use for the treatment of diabetic eye disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3481913D1 (en) * 1983-04-27 1990-05-17 Ici America Inc PROLIN DERIVATIVES.
FR2667864B2 (en) * 1990-03-07 1994-08-05 Rhone Poulenc Sante N-PHENYL GLYCINAMIDE DERIVATIVES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
FR2678938B1 (en) * 1991-07-10 1993-10-08 Rhone Poulenc Rorer Sa PYRROLIDINE DERIVATIVES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.

Also Published As

Publication number Publication date
DE69400704D1 (en) 1996-11-14
IL108288A0 (en) 1994-04-12
KR960700229A (en) 1996-01-19
NO952688L (en) 1995-08-29
ATE143947T1 (en) 1996-10-15
FR2700166B1 (en) 1995-02-17
GR3021314T3 (en) 1997-01-31
ZA9429B (en) 1994-08-11
NO952688D0 (en) 1995-07-06
ES2094638T3 (en) 1997-01-16
HUT74094A (en) 1996-11-28
US5707991A (en) 1998-01-13
AU5819394A (en) 1994-08-15
JPH08505849A (en) 1996-06-25
NZ259399A (en) 1996-07-26
WO1994015915A1 (en) 1994-07-21
CA2152185A1 (en) 1994-07-21
EP0678089A1 (en) 1995-10-25
DE69400704T2 (en) 1997-03-13
FR2700166A1 (en) 1994-07-08
DK0678089T3 (en) 1996-11-18
EP0678089B1 (en) 1996-10-09

Similar Documents

Publication Publication Date Title
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
DE69425431D1 (en) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
HU9502065D0 (en) Application of carbamazepine and oxcarbazepine in the treatment of parkinson&#39;s disease and parkinsonian syndromes
ZA9479B (en) Thiazolidine derivatives their preparation and medicinal products containing them
FI972434A0 (en) Pharmaceutical composition containing lamotrigine
GR3021314T3 (en) N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
IL113665A0 (en) Amide derivatives their preparation pharmaceutical compositions containing them and their use
HU9502067D0 (en) N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders
TW261605B (en)
IL108283A0 (en) Use of riluzole for promoting restoration following radiation

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment